B. Brockstein

A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma

R. McLendon, E. Vokes, C. Ryan, 2006, Cancer Chemotherapy and Pharmacology.

Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model.

K. Griffith, S. Schuetze, W. Stadler, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.

M. Ratain, S. Lippman, R. Stupp, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.

A. Rademaker, R. Weichselbaum, E. Vokes, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An open-label multicenter phase II study of bevacizumab for the treatment of angiosarcoma.

M. von Mehren, S. Okuno, M. Agulnik, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.

M. Ratain, E. Vokes, D. Haraf, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer.

E. Vokes, D. Haraf, K. Stenson, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.